Mariona Figols

6PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Integrating the Neutrophil-to-Lymphocyte Ratio into a Clinicopathological Nomogram for Event-Free Survival Prediction in Cisplatin-Treated Muscle-Invasive Bladder Cancer.

|May 07, 2026
Overcoming T cell exhaustion and senescence in CAR T cell therapy for solid tumors.

|Nov 27, 2025
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer.

Vicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín

|Jul 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN Expression.

Marta Garcia de Herreros, Natalia Jiménez, Joan Padrosa

|May 07, 2025
Tumor-Educated Platelets in Urological Tumors: A Novel Biosource in Liquid Biopsy.

Mariona Figols, Sviatoslav Chekhun, Maria Fernández-Saorin

|Oct 14, 2022
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.

Natalia Jiménez, Òscar Reig, Mercedes Marín-Aguilera

Pageof 1

Frequent Collaborators

5 joint publications

Vicenç Ruiz de Porras

2 joint publications

Natalia Jiménez

2 joint publications

Laura Ferrer-Mileo

2 joint publications

Isabel Chirivella